Plasma cholinesterase deficiency

Area of Science:

• Biochemistry
• Anesthesiology
• Pharmacology

Background:

• Plasma cholinesterase (PCE) is crucial for metabolizing specific anesthetic agents.
• Abnormal PCE activity, including reduced levels or atypical genotypes, can impair drug metabolism.
• This impairment can lead to prolonged neuromuscular blockade following administration of muscle relaxants like succinylcholine and mivacurium.

Purpose of the Study:

• To review perianesthesia nursing considerations for patients with abnormal PCE activity.
• To discuss treatment modalities for prolonged paralytic responses associated with PCE deficiency.
• To highlight the clinical significance of identifying and managing patients with atypical cholinesterase.

Main Methods:

• Literature review of perianesthesia nursing practices.
• Analysis of treatment strategies for prolonged neuromuscular blockade.
• Synthesis of information on PCE genotypes and their clinical implications.

Main Results:

• Patients with abnormal PCE activity are at risk for prolonged paralysis.
• Specific nursing interventions are required for safe perianesthesia care.
• Management strategies focus on supportive care and monitoring until muscle function returns.

Conclusions:

• Understanding PCE activity is vital for safe anesthetic management.
• Perianesthesia nurses play a key role in identifying and managing patients at risk.
• Appropriate treatment and supportive care can mitigate risks associated with prolonged paralysis.